Final answer:
The anticoagulants approved for stroke prevention in non-valvular atrial fibrillation (A fib) include Rivaroxaban, Dabigatran, Apixaban, Heparin, and Warfarin.
Step-by-step explanation:
Anticoagulants approved for stroke prevention in non-valvular atrial fibrillation (A fib) include:
- Rivaroxaban (Xarelto)
- Dabigatran (Pradaxa)
- Apixaban (Eliquis)
- Heparin
- Warfarin (Coumadin)
These anticoagulants are often prescribed to prevent first or recurrent strokes and may prevent clots from becoming larger and causing more serious problems. They are commonly used in patients with non-valvular atrial fibrillation, which is a type of irregular heartbeat.